The Scientific Research Team at Convelo Therapeutics is responsible for identifying and validating key biological targets, as well as advancing a pipeline of drug candidates aimed at regenerating the myelin coating around nerve cells. This team conducts cutting-edge research and discovery work, encompassing various aspects of biology and pharmacology, to develop novel therapeutic solutions for neurological diseases such as multiple sclerosis, pediatric leukodystrophies, and Alzheimer's.
View all